DNA engineered micromotors powered by metal nanoparticles for motion based cellphone diagnostics

Area of Science:

• Biotechnology
• Molecular Diagnostics
• Mobile Health

Background:

• Human Immunodeficiency Virus type 1 (HIV-1) remains a significant global health challenge.
• Existing diagnostic methods can be costly, slow, or require specialized laboratory equipment.
• Integrating mobile health (mHealth) with advanced biosensing offers potential for improved HIV-1 management.

Purpose of the Study:

• To develop and validate a novel, portable platform for the molecular detection of HIV-1 RNA.
• To integrate cellphone-based optical sensing with bioengineered catalytic motors for sensitive diagnostics.
• To assess the diagnostic performance of the platform at a clinically relevant threshold.

Main Methods:

• A platform combining cellphone optical sensing, loop-mediated isothermal DNA amplification (LAMP), and micromotor motion was developed.
• Detection relies on the reduction of micromotor motion caused by amplicon formation from HIV-1 RNA.
• The change in motor motion was quantified using a cellphone system as a biomarker.

Main Results:

• The platform achieved qualitative detection of HIV-1 RNA in samples (n=54).
• Demonstrated high diagnostic accuracy with 99.1% specificity and 94.6% sensitivity.
• Effective detection was achieved at a threshold of 1000 virus particles/ml.

Conclusions:

• The developed cellphone-based system offers a sensitive and portable method for HIV-1 detection.
• This technology has the potential to enable rapid, low-cost diagnostics for HIV-1 and other infectious diseases.
• The integration of mHealth and microfluidic devices represents a promising avenue for point-of-care diagnostics.